abstract |
Formula (I): Wherein all symbols are defined in the detailed description. Also, a pharmaceutical composition containing the compound, a method for producing the compound, a kit containing the compound, and treatment of TREK-1, TREK-2, or a disorder associated with TREK-1 and TREK-2 disease in a mammal. Also disclosed are methods of using the compounds, compositions and kits for |